CLINICAL_TRIALS
trial_result
· 2017-08-01
Clinical Trial Update: Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants [Phase 1]
Summary
The document reports completion of a Phase 1 pharmacokinetics and metabolism study of radiolabeled BMS-986231 in healthy male participants.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Heart Decompensation, Acute | Phase 1 | Status: COMPLETED